We respond to a report from the IPPR and CF suggesting it could take over a decade to clear the cancer treatment backlog in England

Baroness Delyth Morgan, Chief Executive at Breast Cancer Now, said: “These alarming estimates lay bare just how urgently investment in...

24 September 2021

We respond to new data for Enhertu presented at the European Society for Medical Oncology (ESMO) conference

Dr Kotryna Temcinaite, Senior Research Communications Manager Breast Cancer Now, said: “It is fantastic to see that trastuzumab deruxtecan (...

19 September 2021

We respond to news of NHS England and Amgen reaching a national agreement to enable early access to Sotorasib for eligible lung cancer patients in England

Baroness Delyth Morgan, Chief Executive at Breast Cancer Now, said: “Lung cancer patients today received welcome news of interim access to a...

10 September 2021

We respond to Macmillan Cancer Support's new research revealing severe nurse shortages are putting cancer patients at risk

Dr Simon Vincent, Director of Research, Support and Influencing at Breast Cancer Now, said: “These revelations paint a really frightening...

8 September 2021

Breast Cancer Now welcomes NICE approval of abemaciclib with fulvestrant for routine use on the NHS

The National Institute for Health and Care Excellence (NICE) has today (Thursday 12th August 2021) announced its decision to approve abemaciclib with...

12 August 2021

Breast Cancer Now welcomes NICE approval of abemaciclib with fulvestrant for routine use on the NHS

The National Institute for Health and Care Excellence (NICE) has today (Thursday 12th August 2021) announced its decision to approve abemaciclib with...

12 August 2021

We respond to a new study into the use of ErSO to shrink oestrogen receptor positive breast cancer in mice

Dr Kotryna Temcinaite, Senior Research Communications Manager at Breast Cancer Now, said: “Each year in the UK around 55,000 women are diagnosed...

22 July 2021

We respond to announcement from NHS England of a new Innovative Medicines Fund

Baroness Delyth Morgan, Chief Executive at Breast Cancer Now, said: “The Cancer Drugs Fund has already changed the lives of thousands of...

21 July 2021

We respond to the latest census of clinical oncologists from The Royal College of Radiologists

Baroness Delyth Morgan, Chief Executive at Breast Cancer Now, said: “The 11% vacancy rate for breast consultant clinical oncologists across...

14 July 2021